1. Home
  2. DAC vs FTRE Comparison

DAC vs FTRE Comparison

Compare DAC & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Danaos Corporation

DAC

Danaos Corporation

HOLD

Current Price

$101.00

Market Cap

1.7B

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$17.37

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAC
FTRE
Founded
1972
1996
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
DAC
FTRE
Price
$101.00
$17.37
Analyst Decision
Strong Buy
Buy
Analyst Count
1
9
Target Price
$105.00
$15.56
AVG Volume (30 Days)
70.0K
1.3M
Earning Date
02-09-2026
03-02-2026
Dividend Yield
3.58%
N/A
EPS Growth
N/A
N/A
EPS
25.05
N/A
Revenue
$1,034,370,000.00
$2,759,900,000.00
Revenue This Year
N/A
$3.17
Revenue Next Year
N/A
$0.07
P/E Ratio
$4.02
N/A
Revenue Growth
2.90
1.88
52 Week Low
$65.40
$3.97
52 Week High
$102.20
$19.00

Technical Indicators

Market Signals
Indicator
DAC
FTRE
Relative Strength Index (RSI) 66.00 57.07
Support Level $98.41 $15.37
Resistance Level $101.72 $17.24
Average True Range (ATR) 2.04 1.20
MACD 0.30 -0.23
Stochastic Oscillator 90.52 61.21

Price Performance

Historical Comparison
DAC
FTRE

About DAC Danaos Corporation

Danaos Corp is an international owner of containerships. It provides international seaborne transportation services by operating vessels in the containership sector of the shipping industry. The company's customers include, HMM, MSC, Yang Ming, Hapag Lloyd, ZIM, Maersk, COSCO, OOCL, ONE, PIL, Sealead, Niledutch, Samudera, OSC, and Arkas. Geographically, the company operates in Australia-Asia, Europe, and America, with maximum revenue from the Australia-Asia region. It has two reporting segments Container vessels and Drybulk vessels segment. It generates the majority of its revenue from Container vessels.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: